King & Spalding, assisted by Richards, Layton and Fingers, has advised CG Oncology. A jury in the Superior Court of the State of Delaware has found...
Jury Finds in Favor of CG Oncology in $2.3 Billion Royalty Dispute with ANI Pharmaceuticals
CG Oncology’s $105 Million Financing Round
Wilson Sonsini Goodrich & Rosati advised Foresite Capital on the transaction. CG Oncology, Inc. announced the close of an oversubscribed $105 million crossover financing round, co-led...
CG Oncology’s $120 Million Series E Financing Round
Latham & Watkins LLP represented CG Oncology in the transaction. CG Oncology, Inc., an oncolytic immunotherapy company focused on developing novel therapeutics for patients with urologic...